WRN inhibitor 14 (S35) is an orally bioavailable small molecule targeting the WRN helicase for cancer research. It demonstrates in vivo efficacy by inhibiting tumor growth in SW48 xenograft models in mice, supporting its study in microsatellite unstable (MSI) cancers.
Molecular Weight:
756.75
Formula:
C35H40F4N10O5
Target:
DNA/RNA Synthesis
* VAT and and shipping costs not included. Errors and price changes excepted
